# Vascular Dysfunction in Human Obesity Hypertension

> **NCT01983462** · PHASE2 · TERMINATED · sponsor: **Gary L. Pierce** · enrollment: 33 (actual)

## Conditions studied

- Obesity
- Prehypertension
- Hypertension

## Interventions

- **DRUG:** Clonidine
- **DRUG:** Hydrochlorothiazide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01983462
- **Lead sponsor:** Gary L. Pierce
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Funding expired
- **Last updated:** 2023-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01983462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01983462, "Vascular Dysfunction in Human Obesity Hypertension". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01983462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*